Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment

Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Frederik Uttenthal, Wilhjelm, Johannes Katate, Nielsen, Eric Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289095/
https://www.ncbi.nlm.nih.gov/pubmed/34316730
http://dx.doi.org/10.1016/j.jaccas.2019.04.004
_version_ 1783724228017651712
author Larsen, Frederik Uttenthal
Wilhjelm, Johannes Katate
Nielsen, Eric Steen
author_facet Larsen, Frederik Uttenthal
Wilhjelm, Johannes Katate
Nielsen, Eric Steen
author_sort Larsen, Frederik Uttenthal
collection PubMed
description Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of promising advances in treatment with immune checkpoint inhibitors. (Level of Difficulty: Advanced.)
format Online
Article
Text
id pubmed-8289095
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82890952021-07-26 Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment Larsen, Frederik Uttenthal Wilhjelm, Johannes Katate Nielsen, Eric Steen JACC Case Rep Case Report Malignant melanoma demonstrates the highest rate of cardiac metastases. The incidence of melanoma is rising. The prognosis of people with advanced melanoma is generally poor. This case report emphasizes the potential need for early detection of cardiac involvement in advanced melanoma in view of promising advances in treatment with immune checkpoint inhibitors. (Level of Difficulty: Advanced.) Elsevier 2019-06-19 /pmc/articles/PMC8289095/ /pubmed/34316730 http://dx.doi.org/10.1016/j.jaccas.2019.04.004 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Larsen, Frederik Uttenthal
Wilhjelm, Johannes Katate
Nielsen, Eric Steen
Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_full Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_fullStr Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_full_unstemmed Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_short Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
title_sort remission of a perimyocardial melanoma metastasis with pembrolizumab treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289095/
https://www.ncbi.nlm.nih.gov/pubmed/34316730
http://dx.doi.org/10.1016/j.jaccas.2019.04.004
work_keys_str_mv AT larsenfrederikuttenthal remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment
AT wilhjelmjohanneskatate remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment
AT nielsenericsteen remissionofaperimyocardialmelanomametastasiswithpembrolizumabtreatment

Ejemplares similares